Literature DB >> 11417610

Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome.

L Burd1, P J Kerbeshian, A Barth, M G Klug, P K Avery, B Benz.   

Abstract

The goal of this study was to collect prospective longitudinal information on the development of an epidemiologically defined cohort of patients with Tourette syndrome. These data may improve prognostic understanding of the condition. This information will also be important for specification of an adult phenotype for genetic marker studies. A prospective longitudinal cohort study was conducted. Fifty-four of 73 patients from our 1986 prevalence study of Tourette syndrome in North Dakota school-aged children were eligible for inclusion. The subjects were diagnosed in 1984 and 1985. We were able to interview 39 of 54 eligible patients for 507 person-years of follow-up. For the cohort, tic severity declined by 59%, global assessment of functioning improved by 50%, and the average number of comorbidities decreased by 42%. Forty-four percent of patients were essentially symptom free at follow-up. Only 22% were on medication as adults. Tourette syndrome is a developmental neuropsychiatric disorder with a long-term course that is favorable for most patients. Males demonstrated substantially more variability in improvement but overall demonstrated more improvement than females.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417610     DOI: 10.1177/088307380101600609

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  22 in total

1.  Neural substrates of self-regulatory control in children and adults with Tourette syndrome.

Authors:  Amir Raz; Hongtu Zhu; Shan Yu; Ravi Bansal; Zhishun Wang; Gerianne M Alexander; Jason Royal; Bradley S Peterson
Journal:  Can J Psychiatry       Date:  2009-09       Impact factor: 4.356

2.  Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study.

Authors:  Daniel A Gorman; Nancy Thompson; Kerstin J Plessen; Mary M Robertson; James F Leckman; Bradley S Peterson
Journal:  Br J Psychiatry       Date:  2010-07       Impact factor: 9.319

3.  European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Andrea E Cavanna; Sandra Dehning; Mauro Porta; Mary M Robertson; Veerle Visser-Vandewalle
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

4.  Tourette syndrome in an elderly patient.

Authors:  P Voitsidis; K Diamantopoulos; I Gliatas; I Diakogiannis; E Parlapani
Journal:  Hippokratia       Date:  2019 Jan-Mar       Impact factor: 0.471

5.  Bridging neuroscience and clinical psychology: cognitive behavioral and psychophysiological models in the evaluation and treatment of Gilles de la Tourette syndrome.

Authors:  Marc E Lavoie; Julie Leclerc; Kieron P O'Connor
Journal:  Neuropsychiatry (London)       Date:  2013-02-01

Review 6.  The prognosis of Tourette syndrome: implications for clinical practice.

Authors:  Nadiya Hassan; Andrea E Cavanna
Journal:  Funct Neurol       Date:  2012 Jan-Mar

7.  Attentional performance in children and adolescents with tic disorder and co-occurring attention-deficit/hyperactivity disorder: new insights from a 2 × 2 factorial design study.

Authors:  Ellen Greimel; Sina Wanderer; Aribert Rothenberger; Beate Herpertz-Dahlmann; Kerstin Konrad; Veit Roessner
Journal:  J Abnorm Child Psychol       Date:  2011-08

8.  Tourette syndrome and other tic disorders in childhood, adolescence and adulthood.

Authors:  Andrea G Ludolph; Veit Roessner; Alexander Münchau; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

9.  Developmental psychopathology of children and adolescents with Tourette syndrome--impact of ADHD.

Authors:  Veit Roessner; Andreas Becker; Tobias Banaschewski; Roger D Freeman; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-06       Impact factor: 4.785

10.  Inhibitory deficits in Tourette's syndrome.

Authors:  Emily R Stern; Clancy Blair; Bradley S Peterson
Journal:  Dev Psychobiol       Date:  2008-01       Impact factor: 3.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.